- Home
- SSTK vs IMTX Comparison
SSTK vs IMTX Comparison
Compare SSTK & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSTK
- IMTX
- Stock Information
- Founded
- SSTK 2003
- IMTX N/A
- Country
- SSTK United States
- IMTX Germany
- Employees
- SSTK N/A
- IMTX N/A
- Industry
- SSTK EDP Services
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSTK Technology
- IMTX Health Care
- Exchange
- SSTK Nasdaq
- IMTX Nasdaq
- Market Cap
- SSTK 644.4M
- IMTX 579.8M
- IPO Year
- SSTK 2012
- IMTX N/A
- Fundamental
- Price
- SSTK $18.45
- IMTX $5.42
- Analyst Decision
- SSTK Buy
- IMTX Strong Buy
- Analyst Count
- SSTK 4
- IMTX 4
- Target Price
- SSTK $43.67
- IMTX $14.67
- AVG Volume (30 Days)
- SSTK 274.5K
- IMTX 826.9K
- Earning Date
- SSTK 08-05-2025
- IMTX 08-12-2025
- Dividend Yield
- SSTK 7.12%
- IMTX N/A
- EPS Growth
- SSTK N/A
- IMTX N/A
- EPS
- SSTK 1.09
- IMTX N/A
- Revenue
- SSTK $963,567,000.00
- IMTX $155,801,989.00
- Revenue This Year
- SSTK $11.31
- IMTX N/A
- Revenue Next Year
- SSTK $2.40
- IMTX $1.92
- P/E Ratio
- SSTK $17.09
- IMTX N/A
- Revenue Growth
- SSTK 10.30
- IMTX 93.56
- 52 Week Low
- SSTK $14.35
- IMTX $3.30
- 52 Week High
- SSTK $46.10
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- SSTK 51.11
- IMTX 47.76
- Support Level
- SSTK $18.43
- IMTX $5.29
- Resistance Level
- SSTK $19.05
- IMTX $5.60
- Average True Range (ATR)
- SSTK 0.76
- IMTX 0.31
- MACD
- SSTK 0.01
- IMTX -0.11
- Stochastic Oscillator
- SSTK 41.27
- IMTX 16.06
About SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.